These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2013987)
21. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376 [TBL] [Abstract][Full Text] [Related]
22. [Objective evaluation of selective peripheral denervation for spasmodic torticollis]. Taira T; Kawamura H; Tanikawa T; Kawabatake H; Iseki H; Imamura T; Atsuchi M; Kawashima A; Takakura K No Shinkei Geka; 1997 Oct; 25(10):927-32. PubMed ID: 9330396 [TBL] [Abstract][Full Text] [Related]
23. Selective peripheral denervation for the treatment of spasmodic torticollis: long-term follow-up results from 648 patients. Wang J; Li J; Han L; Guo S; Wang L; Xiong Z; Ma J; Liang J; Wang L Acta Neurochir (Wien); 2015 Mar; 157(3):427-33; discussion 433. PubMed ID: 25616622 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of spasmodic torticollis by local injections of botulinum toxin]. Jedynak CP; de Saint Victor JF Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409 [TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients. Cullis PA; O'Brien CF; Truong DD; Koller M; Villegas TP; Wallace JD Adv Neurol; 1998; 78():227-30. PubMed ID: 9750919 [No Abstract] [Full Text] [Related]
28. Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation. Chawda SJ; Münchau A; Johnson D; Bhatia K; Quinn NP; Stevens J; Lees AJ; Palmer JD J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):465-71. PubMed ID: 10727482 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of botulinum toxin in the treatment of spasmodic torticollis. Boghen D; Flanders M Eur Neurol; 1993; 33(3):199-203. PubMed ID: 8467837 [TBL] [Abstract][Full Text] [Related]
33. Peripheral neurotomy for torticollis: a new approach. Taira T; Hori T Stereotact Funct Neurosurg; 2001; 77(1-4):40-3. PubMed ID: 12378055 [TBL] [Abstract][Full Text] [Related]
34. [Injection of botulinum toxin as a new treatment of torticollis]. Aquilonius SM; Cesarini KG; Stålberg E Lakartidningen; 1990 Dec; 87(51-52):4408-10. PubMed ID: 2177127 [TBL] [Abstract][Full Text] [Related]
35. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Gelb DJ; Yoshimura DM; Olney RK; Lowenstein DH; Aminoff MJ Ann Neurol; 1991 Apr; 29(4):370-6. PubMed ID: 1929208 [TBL] [Abstract][Full Text] [Related]
36. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment]. Domzał TM Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of spasmodic torticollis with local injections of botulinum toxin A]. Erbguth F; Kilian KD; Claus D; Neundörfer B Dtsch Med Wochenschr; 1991 Apr; 116(15):567-72. PubMed ID: 2013263 [TBL] [Abstract][Full Text] [Related]
38. [Botulinum toxin in therapy of craniocervical dystonia]. Dressler D; Benecke R; Conrad B Nervenarzt; 1989 Jul; 60(7):386-93. PubMed ID: 2668776 [TBL] [Abstract][Full Text] [Related]
39. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin. Metzer WS; Jenkins T J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180 [TBL] [Abstract][Full Text] [Related]
40. Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin. Dykstra D; Ellingham C; Belfie A; Baxter T; Lee M; Voelker A Mov Disord; 1993; 8(1):38-42. PubMed ID: 8419806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]